Suchergebnisse - "Sonneveld, Pieter"

PubPharm (647)

1

A robust gene expression signature to predict proteasome inhibitor benefit in Multiple Myeloma

enthalten in: bioRxiv.org | 2024

von Ubels, J. | Sonneveld, P. | van Vliet, M. | +1

2

Four-Drug Therapy for Multiple Myeloma. Reply

enthalten in: The New England journal of medicine | 2024

von Sonneveld, P.

CommentOn: N Engl J Med. 2024 Jan 25;390(4):301-313. - PMID 38084760

3

An IL-1β-driven neutrophil-stromal cell axis fosters a BAFF-rich protumor microenvironment in individuals with multiple myeloma

enthalten in: Nature immunology | 2024

von de Jong, M. | Fokkema, C. | Papazian, N. | +17

4

Healthcare Resource Utilization and Cost-of-Illness in Systemic Light Chain (AL) Amyloidosis in Europe : Results From the Real-World, Retrospective EMN23 Study

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Jaccard, A. | Bridoux, F. | Roeloffzen, W. | +21

5

Predictors of early morbidity and mortality in newly diagnosed multiple myeloma : data from five randomized, controlled, phase III trials in 3700 patients

enthalten in: Leukemia | 2024

von Mai, E. | Hielscher, T. | Bertsch, U. | +26

6

Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone : analyses from the phase III OCEAN study

enthalten in: Haematologica | 2024

von Schjesvold, F. | Ludwig, H. | Delimpasi, S. | +15

7

Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myeloma

enthalten in: Future oncology (London, England) | 2024

von Costa, L. | LeBlanc, T. | Tesch, H. | +10

8

Melflufen in relapsed/refractory multiple myeloma refractory to prior alkylators : A subgroup analysis from the OCEAN study

enthalten in: European journal of haematology | 2024

von Schjesvold, F. | Ludwig, H. | Mateos, M. | +7

9

Update and European consensus on a patient-centered core outcome set for multiple myeloma in clinical practice and research

enthalten in: Haematologica | 2024

von Oerlemans, S. | De Rooij, B. | Bennink, C. | +15

10

Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

enthalten in: The New England journal of medicine | 2024

von Sonneveld, P. | Dimopoulos, M. | Boccadoro, M. | +141

CommentIn: N Engl J Med. 2024 Apr 18;390(15):1440. - PMID 38631009

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[65]